Current Report No: 33/2023
Legal basis: Article 56 (1) (2) of the Offering Act – current and periodic information
Management Board of Medicalgorithmics S.A. with its seat in Warsaw (“the Company“), hereby informs about the convening of the Extraordinary General Meeting of the Company on December 19, 2023, at 3:30 p.m. at the Company’s seat – at the office at Al. Jerozolimskie 81, 02-001 Warsaw, on the 18th floor of the Central Tower building in Warsaw, in accordance with the content of the announcement attached to this current report.
Attached to this current report, the Company provides the content of draft resolutions to be discussed at the Extraordinary General Meeting of the Company.
The Company indicates that the adoption of the proposed resolutions is aimed at adopting the Remuneration Policy, in accordance with the requirements of the Act on Offering and the provisions of the Company’s existing Remuneration Policy for Members of the Company’s Management Board and Supervisory Board, which requires it to be updated or left unchanged at least once every 3 years, and introducing an incentive program at the Company for members of the Company’s Management Board and key personnel (the “Incentive Program“). Incentive mechanisms as presented in the draft Incentive Program and key assumptions of the Incentive Program were submitted to the Company’s Management Board by the Company’s shareholder BioFund Capital Management LLC, which owns 49.99% of the Company’s shares, and subsequently submitted to the Nomination and Remuneration Committee and the Company’s Supervisory Board for work and received a positive opinion. In the opinion of the Company’s Management Board, the presented shape of the Incentive Program coincides with the interests of shareholders and the Company, and at the same time will significantly increase the competitiveness of the Medicalgorithmics Group as an employer.
Detailed legal basis: § 19 para. 1 point 1) and 2) of the Regulation of the Minister of Finance of March 29, 2018, on current and periodic information published by issuers of securities and conditions for recognizing as equivalent information required by the law of a non-member state.